![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 9
Zeitschriftenartikel
Jacob, Anne Sophie; Kaul, Helen; Fuchs, Michael; Gillessen, Sarah; Kreissl, Stefanie; Pluetschow, Annette; Momotow, Jesko; Schaub, Valdete; Huettmann, Andreas; Haenel, Mathias; Zimmermann, Andreas; Dierlamm, Judith; Meissner, Julia; Mathas, Stephan; Martin, Sonja; Engert, Andreas; Hallek, Michael; Borchmann, Peter und Lehmann, Clara
(2022):
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma.
In: Infection, Bd. 50, Nr. 4: S. 925-932
Borchmann, Peter; Plutschow, Annette; Kobe, Carsten; Greil, Richard; Meissner, Julia; Topp, Max S.; Ostermann, Helmut; Dierlamm, Judith; Mohm, Johannes; Thiemer, Julia; Sokler, Martin; Kerkhoff, Andrea; Ahlborn, Miriam; Halbsguth, Teresa V.; Martin, Sonja; Keller, Ulrich; Balabanov, Stefan; Pabst, Thomas; Vogelhuber, Martin; Huttmann, Andreas; Wilhelm, Martin; Zijlstra, Josee M.; Moccia, Alden; Kuhnert, Georg; Brockelmann, Paul J.; Tresckow, Bastian von; Fuchs, Michael; Klimm, Beate; Rosenwald, Andreas; Eich, Hans; Baues, Christian; Marnitz, Simone; Hallek, Michael; Diehl, Volker; Dietlein, Markus und Engert, Andreas
(2021):
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial.
In: Lancet Oncology, Bd. 22, Nr. 2: S. 223-234
Kreissl, Stefanie; Goergen, Helen; Buehnen, Ina; Kobe, Carsten; Moccia, Alden; Greil, Richard; Eichenauer, Dennis A.; Zijlstr, Josee M.; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Soekler, Martin; Beck, Hans Joachim; Willenbacher, Wolfgang; Ludwig, Wol-Dieter; Pabst, Thomas; Topp, Max S.; Hitz, Felicitas; Bentz, Martin; Keller, Ulrich Bernd; Kuehnhardt, Dagmar; Ostermann, Helmut; Hertenstein, Bernd; Ulitzky, Wafter A.; Maschmeyer, Georg; Vieler, Tons; Eich, Hans; Baues, Christian; Stein, Harald; Fuchs, Michael; Diehl, Volker; Dietlein, Markus; Engert, Andreas und Borchmann, Peter
(2021):
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.
In: Lancet Haematology, Bd. 8, Nr. 6, E398-E409
Witzens-Harig, Mathias; Viardot, Andreas; Keller, Ulrich; Wosniok, Julia; Deuster, Oliver; Klemmer, Jennifer; Geueke, Anne-Marie; Meissner, Julia; Ho, Anthony D.; Atta, Johannes; Marks, Reinhard; La Rosee, Paul; Buske, Christian; Dreyling, Martin H. und Hess, Georg
(2021):
The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL - Results From the Phase-II STORM Trial.
In: Hemasphere, Bd. 5, Nr. 10, e636
Broeckelmann, Paul J.; Goergen, Helen; Keller, Ulrich; Meissner, Julia; Ordemann, Rainer; Halbsguth, Teresa V.; Sasse, Stephanie; Soekler, Martin; Kerkhoff, Andrea; Mathas, Stephan; Huettmann, Andreas; Bormann, Matthias; Zimmermann, Andreas; Mettler, Jasmin; Fuchs, Michael; Tresckow, Bastian von; Baues, Christian; Rosenwald, Andreas; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter und Engert, Andreas
(2020):
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.
In: Jama Oncology, Bd. 6, Nr. 6: S. 872-880
Dittrich, Ralf; Kliesch, Sabine; Schüring, Andreas; Balcerek, Magdalena; Baston-Buest, Dunja M.; Beck, Ramona; Beckmann, Matthias W.; Behringer, Karolin; Borgmann-Staudt, Anja; Cremer, Wolfgang; Denzer, Christian; Diemer, Thorsten; Dorn, Almut; Fehm, Tanja; Gaase, Rüdiger; Germeyer, Ariane; Geue, Kristina; Ghadjar, Pirus; Göckenjan, Maren; Götte, Martin; Guth, Dagmar; Hauffa, Berthold P.; Hehr, Ute; Hetzer, Franc; Hirchenhain, Jens; Hoffmann, Wilfried; Hornemann, Beate; Jantke, Andreas; Kentenich, Heribert; Kiesel, Ludwig; Köhn, Frank-Michael; Korell, Matthias; Lax, Sigurd; Liebenthron, Jana; Lux, Michael; Meissner, Julia; Micke, Oliver; Nassar, Najib; Nawroth, Frank; Nordhoff, Verena; Ochsendorf, Falk; Oppelt, Patricia G.; Pelz, Jörg; Rau, Beate; Reisch, Nicole; Riesenbeck, Dorothea; Schlatt, Stefan; Sender, Annekathrin; Schwab, Roxana; Siedentopf, Friederike; Thorn, Petra; Wagner, Steffen; Wildt, Ludwig; Wimberger, Pauline; Wischmann, Tewes; Wolff, Michael von und Lotz, Laura
(2018):
Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) - Recommendations and Statements for Girls and Women.
In: Geburtshilfe und Frauenheilkunde, Bd. 78, Nr. 6: S. 567-583
Borchmann, Peter; Goergen, Helen; Kobe, Carsten; Lohri, Andreas; Greil, Richard; Eichenauer, Dennis A.; Zijlstra, Josee M.; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Hüttmann, Andreas; Dierlamm, Judith; Sökler, Martin; Beck, Hans-Joachim; Willenbacher, Wolfgang; Ludwig, Wolf-Dieter; Pabst, Thomas; Topp, Max S.; Hitz, Felicitas; Bentz, Martin; Keller, Ulrich Bernd; Kuhnhardt, Dagmar; Ostermann, Helmut; Schmitz, Norbert; Hertenstein, Bernd; Aulitzky, Walter; Maschmeyer, Georg; Vieler, Tom; Eich, Hans; Baues, Christian; Stein, Harald; Fuchs, Michael; Kuhnert, Georg; Diehl, Volker; Dietlein, Markus und Engert, Andreas
(2017):
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
In: Lancet, Bd. 390, Nr. 10114: S. 2790-2802
Borchmann, Peter; Haverkamp, Heinz; Lohri, Andreas; Mey, Ulrich; Kreissl, Stefanie; Greil, Richard; Markova, Jana; Feuring-Buske, Michaela; Meissner, Julia; Duehrsen, Ulrich; Ostermann, Helmut; Keller, Ulrich; Maschmeyer, Georg; Kuhnert, Georg; Dietlein, Markus; Kobe, Carsten; Eich, Hans; Baues, Christian; Stein, Harald; Fuchs, Michael; Diehl, Volker und Engert, Andreas
(2017):
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP(escalated) alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
In: Lancet Oncology, Bd. 18, Nr. 4: S. 454-463
Eichenauer, Dennis A.; Plütschow, Annette; Kreissl, Stefanie; Sökler, Martin; Hellmuth, Johannes C.; Meissner, Julia; Mathas, Stephan; Topp, Max S.; Behringer, Karolin; Klapper, Wolfram; Kuhnert, Georg; Dietlein, Markus; Kobe, Carsten; Fuchs, Michael; Diehl, Volker; Engert, Andreas und Borchmann, Peter
(2017):
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
In: Lancet Oncology, Bd. 18, Nr. 12: S. 1680-1687